Pulmonary impairment, not muscle injury, is associated with elevated ESR in the idiopathic inflammatory myopathies

Rheumatology (United Kingdom)

Volumn 52, Issue 7, 2013, Pages 1336-1338

  Park, Jin Kyun ^a,b   Gelber, Allan C ^a   George, Michael ^a,c   Danoff, Sonye K ^a   Qubti, Marzouq A ^a   Christopher Stine, Lisa ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Seoul National University Hospital   (South Korea)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; PREDNISONE;

DISEASE ASSOCIATION; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FORCED VITAL CAPACITY; HEMATOCRIT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LUNG DISEASE; MUSCLE INJURY; MYOSITIS; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ANTIBODIES, ANTI-IDIOTYPIC; BLOOD SEDIMENTATION; CREATINE KINASE; FEMALE; FRUCTOSE-BISPHOSPHATE ALDOLASE; HUMANS; LIGASES; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MYOSITIS; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84879807979     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket162     Document Type: Letter

References (10)

1. Edwards RH, Isenberg DA, Wiles CM et al. The investigation of inflammatory myopathy. J R Coll Physicians Lond 1981;15:19-24.
2. Amerio P, Girardelli CR, Proietto G et al. Usefulness of erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis. Eur J Dermatol 2002;12: 165-9.
3. Kang EH, Lee EB, Shin KC et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology 2005;44: 1282-6.
4. Marie I, Hatron PY, Hachulla E et al. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol 1998;25:1336-43.
5. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
6. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
7. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304.
8. Enocsson H, Sjowall C, Skogh T et al. Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares? Arthritis Rheum 2009;60:3755-60.
9. Greenberg SA. Type 1 interferons and myositis. Arthritis Res Ther 2010;12(Suppl 1):S4.
10. Levine SM, Raben N, Xie D et al. Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis. Arthritis Rheum 2007;56:2729-39.